Identification NameAlprostadilStructureOther nameAlprostadil
PGE1
Prostaglandin E1CAS NO.745-65-3Molecular FormulaC20H34O5Molecular Weight354.487 g/mol Chemical and Physical PropertiesAppearanceWhite or slightly yellowish, crystalline powderMelting Point115-116 °CSolubilityWater Solubility 26.7 mg/LQuality standardEP & CP ApplicationDrug IndicationVasodilator Agents
Drugs used to cause dilation of the blood vessels.
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Urological Agents
Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION.Formulations/Preparations
10 MICROGRAMS POWDER FOR SOLUTION FOR INJECTION
ALPROSTADIL 3 MG/G CREAM Handling and storageSafety and HazardsToxic if swallowed [Danger Acute toxicity, oral]
Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]Handling and storageStore unopened foil pouches in a refrigerator at 2°– 8°C (36°– 46°F). Do not expose to temperatures above 30°C (86°F).Sample packageAluminium foil bagCommercial packageAluminium tinUN CodeNot classfiedHS Code29375000Shipping groupUN 6.1Sales restrictionNOOriginChina Technical SupportAlprostadiol MSDSYesAlprostadiol COAYesAlprostadiol Transport certificateYesAlprostadiol STDYes Supply abilityMonthly capacityMore than 1.0KGGMPFactory GMP Related APIsRelated ProstaglandinsAlprostadil
Bimatoprost
Dinoprost Trometamol
Dinoprostone